Elyse Stock, Chief Medical Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 57,242 shares at $64.89 ($3.7M) on 2020-06-12, disclosed to the SEC on 2020-06-12.
Open-market sale of $3.7M BHVN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.02 | 4,351 | $274K | 7.4% |
| 2 | $63.02 | 4,351 | $274K | 7.4% |
| 3 | $64.05 | 5,300 | $339K | 9.2% |
| 4 | $64.89 | 15,925 | $1.0M | 27.9% |
| 5 | $64.89 | 15,925 | $1.0M | 27.9% |
| 6 | $65.80 | 11,390 |
| $749K |
| 20.2% |
| Total | $64.71 avg | 57,242 | $3.7M | 100% |
| Filing → |
| BHVN | SELL | 2019-10-17 | $36K | — | Filing → |